These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 12927306

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Increased antiviral activity of 1-O-hexadecyloxypropyl-[2-(14)C]cidofovir in MRC-5 human lung fibroblasts is explained by unique cellular uptake and metabolism.
    Aldern KA, Ciesla SL, Winegarden KL, Hostetler KY.
    Mol Pharmacol; 2003 Mar; 63(3):678-81. PubMed ID: 12606777
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of oral active ether lipid analogs of cidofovir in a lethal mousepox model.
    Buller RM, Owens G, Schriewer J, Melman L, Beadle JR, Hostetler KY.
    Virology; 2004 Jan 20; 318(2):474-81. PubMed ID: 14972516
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Oral treatment of cowpox and vaccinia virus infections in mice with ether lipid esters of cidofovir.
    Quenelle DC, Collins DJ, Wan WB, Beadle JR, Hostetler KY, Kern ER.
    Antimicrob Agents Chemother; 2004 Feb 20; 48(2):404-12. PubMed ID: 14742188
    [Abstract] [Full Text] [Related]

  • 6. Enhanced inhibition of orthopoxvirus replication in vitro by alkoxyalkyl esters of cidofovir and cyclic cidofovir.
    Kern ER, Hartline C, Harden E, Keith K, Rodriguez N, Beadle JR, Hostetler KY.
    Antimicrob Agents Chemother; 2002 Apr 20; 46(4):991-5. PubMed ID: 11897580
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Synthesis, metabolic stability and antiviral evaluation of various alkoxyalkyl esters of cidofovir and 9-(S)-[3-hydroxy-2-(phosphonomethoxy)propyl]adenine.
    Ruiz J, Beadle JR, Buller RM, Schreiwer J, Prichard MN, Keith KA, Lewis KC, Hostetler KY.
    Bioorg Med Chem; 2011 May 01; 19(9):2950-8. PubMed ID: 21493074
    [Abstract] [Full Text] [Related]

  • 10. Alkoxyalkyl esters of cidofovir and cyclic cidofovir exhibit multiple-log enhancement of antiviral activity against cytomegalovirus and herpesvirus replication in vitro.
    Beadle JR, Hartline C, Aldern KA, Rodriguez N, Harden E, Kern ER, Hostetler KY.
    Antimicrob Agents Chemother; 2002 Aug 01; 46(8):2381-6. PubMed ID: 12121908
    [Abstract] [Full Text] [Related]

  • 11. Enhanced antiproliferative effects of alkoxyalkyl esters of cidofovir in human cervical cancer cells in vitro.
    Hostetler KY, Rought S, Aldern KA, Trahan J, Beadle JR, Corbeil J.
    Mol Cancer Ther; 2006 Jan 01; 5(1):156-9. PubMed ID: 16432174
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Smallpox vaccination and adverse reactions. Guidance for clinicians.
    Cono J, Casey CG, Bell DM, Centers for Disease Control and Prevention.
    MMWR Recomm Rep; 2003 Feb 21; 52(RR-4):1-28. PubMed ID: 12617510
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Mutations in the E9L polymerase gene of cidofovir-resistant vaccinia virus strain WR are associated with the drug resistance phenotype.
    Kornbluth RS, Smee DF, Sidwell RW, Snarsky V, Evans DH, Hostetler KY.
    Antimicrob Agents Chemother; 2006 Dec 21; 50(12):4038-43. PubMed ID: 16982794
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. In vitro activity of potential anti-poxvirus agents.
    Kern ER.
    Antiviral Res; 2003 Jan 21; 57(1-2):35-40. PubMed ID: 12615301
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.